Kinnate Biopharma Inc
(KNTE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2018 | 12-2017 | 12-2006 | |
| Cash Flows From Operating Activities | |||
| Net Income | -7,630 | N/A | N/A |
| Accounts receivable | -1,078 | N/A | N/A |
| Other Working Capital | -611 | N/A | N/A |
| Other Operating Activity | 1,117 | 0 | 0 |
| Operating Cash Flow | $-8,202 | $N/A | $N/A |
| Cash Flows From Investing Activities | |||
| Investing Cash Flow | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||
| Common Stock Issued | 3 | N/A | N/A |
| Other Financing Activity | 15,198 | 0 | 0 |
| Financing Cash Flow | $15,201 | $N/A | $N/A |
| End Cash Position | 6,999 | N/A | N/A |
| Net Cash Flow | $6,999 | $N/A | $N/A |
| Free Cash Flow | |||
| Operating Cash Flow | -8,202 | N/A | N/A |
| Free Cash Flow | -8,202 | 0 | 0 |